Vatelizumab Biosimilar – Anti-ITGA2 mAb – Research Grade

Reference:
Product nameVatelizumab Biosimilar - Anti-ITGA2 mAb - Research Grade
SourceCAS 1238217-55-4
SpeciesHumanized
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
ApplicationsELISA,WB
Aliases /SynonymsVatelizumab,GBR500,ITGA2,anti-ITGA2
ReferencePX-TA1276
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG4-kappa
ClonalityMonoclonal Antibody

Description of Vatelizumab Biosimilar - Anti-ITGA2 mAb - Research Grade

General information on Anti-ITGA2[Homo sapiens] (Vatelizumab) Monoclonal Antibody

Vatelizumab has been investigated for the treatment of Ulcerative Colitis.

SDS-PAGE for Vatelizumab Biosimilar - Anti-ITGA2 mAb

Vatelizumab Biosimilar - Anti-ITGA2 mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Vatelizumab Biosimilar – Anti-ITGA2 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Integrin_alpha2 domain-containing protein(ITGA2B)
Antigen

Integrin_alpha2 domain-containing protein(ITGA2B)

PX-P4806 125€
Stable Isotope Labelled Vatelizumab Biosimilar – Anti-ITGA2 mAb – Research Grade
SIL

Stable Isotope Labelled Vatelizumab Biosimilar – Anti-ITGA2 mAb – Research Grade

PX-TA1276-SIL 15000€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products